Steven J. Rice's Insider Trades & SAST Disclosures
Steven J. Rice's most recent trade in Vir Biotechnology Inc was a trade of 2,500 Common Stock done at an average price of $25.7 . Disclosure was reported to the exchange on June 1, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Steven J. Rice.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 25.67 per share. | 01 Jun 2023 | 2,500 | 106,840 (0%) | 0% | 25.7 | 64,175 | Common Stock |
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 73,000 | 110,209 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 46,000 | 46,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 25.97 per share. | 22 Feb 2023 | 1,795 | 108,414 (0%) | 0% | 26.0 | 46,622 | Common Stock |
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 25.29 per share. | 17 Feb 2023 | 1,981 | 37,209 (0%) | 0% | 25.3 | 50,096 | Common Stock |
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 20,000 | 38,658 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 31.93 per share. | 17 Feb 2022 | 1,942 | 18,658 (0%) | 0% | 31.9 | 62,010 | Common Stock |
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.76 per share. | 30 Nov 2021 | 10,000 | 30,600 (0%) | 0% | 12.8 | 127,600 | Common Stock |
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 10,000 | 424,441 | - | - | Employee Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 30 Nov 2021 | 10,000 | 20,600 (0%) | 0% | 50 | 500,000 | Common Stock |
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.76 per share. | 23 Aug 2021 | 10,000 | 30,000 (0%) | 0% | 12.8 | 127,600 | Common Stock |
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 10,000 | 434,441 | - | - | Employee Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 23 Aug 2021 | 10,000 | 20,000 (0%) | 0% | 50 | 500,000 | Common Stock |
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.67 per share. | 25 Jun 2021 | 3 | 20,003 (0%) | 0% | 12.7 | 38 | Common Stock |
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2021 | 3 | 444,441 | - | - | Employee Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 25 Jun 2021 | 3 | 20,000 (0%) | 0% | 50 | 150 | Common Stock |
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Steven J. Rice | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2020 | 40,000 | 40,000 | - | - | Employee Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges